Relmada Therapeutics (RLMD)
NASDAQ:RLMD
Holding RLMD?
Track your performance easily

Relmada Therapeutics (RLMD) Ownership - Who Owns Relmada Therapeutics?

299 Followers

Relmada Therapeutics (RLMD) Ownership Overview

2.40%7.26%4.24%5.66%80.44%
4.24% Other Institutional Investors
5.66% ETFs
80.44% Public Companies and
Individual Investors
The ownership structure of Relmada Therapeutics (RLMD) stock is a mix of institutional, retail, and individual investors. Approximately 17.16% of the company’s stock is owned by Institutional Investors, 2.40% is owned by Insiders, and 80.44% is owned by Public Companies and Individual Investors.
The ownership structure of {name} ({ticker}) stock is a mix of institutional, retail, and individual investors. {displayInstitutionalData, select, display {Approximately {institutionalPercentage} of the company’s stock is owned by Institutional Investors} other {}}{displayInsiderText, select, display {, {insidersPercentage} is owned by Insiders} other {}}{displayInvestorsText, select, display {, and {retailInvestorsPercentage} is owned by Public Companies and Individual Investors.} other {}}

Recent Insider Trading Activity

Date
Name
Activity
Value
Sep 11, 2024
xxxxxxxxxxxxx
$33280
Sep 11, 2024
xxxxxxxxxxxxx
$149701
Sep 11, 2024
xxxxxxxxxxxxx
$64750
Sep 11, 2024
Sergio Traversa
Ceo,director
xxxxxxxxxxxxx
$395115

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Jun 30, 2024
xxxxxxxxxxxxx
$756

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
1,205,541Institution4.00%4,002,396
1,205,541Institution4.00%4,002,396
384,024Insider1.27%1,274,960
374,029Institution1.24%1,241,776
239,353Institution0.79%794,652
224,846Institution0.75%746,489
212,295Insider0.70%704,819
172,777Institution0.57%573,620
93,077Institution0.31%309,016
90,689Institution0.30%301,087

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
1,205,541Institution4.00%4,002,396
374,029Institution1.24%1,241,776
239,353Institution0.79%794,652
172,777Institution0.57%573,620
90,689Institution0.30%301,087
52,182Institution0.17%173,244
20,489Institution0.07%68,023
20,223Institution0.07%67,140
12,505Institution0.04%41,517
3,101Institution0.01%10,295

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
851,916Institution2.82%2,760,208
353,625Institution1.17%1,145,745
224,846Institution0.75%684,726
93,077Institution0.31%318,323
84,420Institution0.28%294,626
54,584Institution0.18%185,586
30,957Institution0.10%105,873
14,428Institution0.05%50,209
4Institution<0.01%14

FAQ

Who Owns Relmada Therapeutics (RLMD)?
According to the latest TipRanks data, approximately 4.24% of the company's stock is held by institutional investors, 2.40% is held by insiders, and 80.44% is held by retail investors.
    What percentage of Relmada Therapeutics (RLMD) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 4.24% of Relmada Therapeutics (RLMD) stock is held by institutional investors.
      What percentage of Relmada Therapeutics (RLMD) stock is held by retail investors?
      According to the latest TipRanks data, approximately 80.44% of Relmada Therapeutics (RLMD) stock is held by retail investors.
        Who owns the most shares of Relmada Therapeutics (RLMD)?
        Vanguard owns the most shares of Relmada Therapeutics (RLMD).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What am I Missing?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis